HUTCHMED (China) Limited
HCM · AIM · Health Care · mcap £1,764m · 215.0p
The statement exactly as printed in one results announcement – its own columns (the period and its comparatives), lines and headings, in the company's currency and units. Choose the report above; to compare several years, use Key figures.
Standardised line items in £m, comparable across companies – figures the company reported in USD are converted to £ at the average rate of each period (balance sheets: at the date); when a later report restated a period, the later figure is shown and marked r (hover for the figure first reported). Italic = calculated (LTM, H2 = FY − H1); a year of other than 12 months is marked (15m). Hover a value for its source.
| June 30, 2026 Assets | December 31, 2025 (Unaudited) | |
|---|---|---|
| Cash and cash equivalents and short-term investments | 1,374,817 | 1,367,275 |
| Accounts receivable | 117,556 | 126,750 |
| Other current assets | 61,036 | 73,317 |
| Property, plant and equipment | 93,788 | 94,623 |
| Investment in equity investees | 11,020 | 10,865 |
| Other non-current assets | 78,210 | 80,267 |
| Total assets | 1,736,427 | 1,753,097 |
| Liabilities and shareholders' equity | ||
| Accounts payable | 33,646 | 45,533 |
| Other payables and accruals | 197,627 | 208,892 |
| Bank borrowings | 94,508 | 93,160 |
| Deferred revenue | 27,630 | 51,547 |
| Other liabilities | 108,048 | 102,703 |
| Total liabilities | 461,459 | 501,835 |
| Company's shareholders' equity | 1,260,776 | 1,237,926 |
| Non-controlling interests | 14,192 | 13,336 |
| Total liabilities and shareholders' equity | 1,736,427 | 1,753,097 |
| (in $'000) 2025 | As of December 31, 2024 | |
|---|---|---|
| Assets | ||
| Cash and cash equivalents and short-term investments | 1,367,275 | 836,110 |
| Accounts receivable | 126,750 | 155,537 |
| Other current assets | 73,317 | 74,908 |
| Property, plant and equipment | 94,623 | 92,498 |
| Investment in equity investees | 10,865 | 77,765 |
| Other non-current assets | 80,267 | 37,378 |
| Total assets | 1,753,097 | 1,274,196 |
| Liabilities and shareholders' equity | ||
| Accounts payable | 45,533 | 42,521 |
| Other payables and accruals | 208,892 | 256,124 |
| Bank borrowings | 93,160 | 82,806 |
| Deferred revenue | 51,547 | 98,503 |
| Other liabilities | 102,703 | 22,389 |
| Total liabilities | 501,835 | 502,343 |
| Company's shareholders' equity | 1,237,926 | 759,929 |
| Non-controlling interests | 13,336 | 11,924 |
| Total liabilities and shareholders' equity | 1,753,097 | 1,274,196 |
| 30 Jun 26 | 31 Dec 25 | 31 Dec 24 | |
|---|---|---|---|
| Non-current assets | |||
| Property, plant & equipment | 70.8 | 70.3 | 73.7 |
| Associates & JVs | 8.3 | 8.1 | 62.0 |
| Current assets | |||
| Total assets | 1,310.1 | 1,301.8 | 1,015.4 |
| Current liabilities | |||
| Borrowings, current | – | 69.2 | 66.0 |
| Non-current liabilities | |||
| Total liabilities | 348.2 | 372.6 | 400.3 |
| Equity | |||
| Non-controlling interests | 10.7 | 9.9 | 9.5 |
Read automatically from each results announcement. Check the source before relying on a figure.
Spotted an error in this income statement? Report it
Company filings. Not investment advice.